LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 45 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $396,113 | +1.8% | 400,000 | 0.0% | 0.06% | +3.8% |
| Q4 2022 | $389,250 | +0.6% | 400,000 | 0.0% | 0.05% | -8.6% |
| Q3 2022 | $387,000 | +1.0% | 400,000 | 0.0% | 0.06% | +3.6% |
| Q2 2022 | $383,000 | -43.7% | 400,000 | -42.9% | 0.06% | -33.3% |
| Q1 2022 | $680,000 | -2.4% | 700,000 | 0.0% | 0.08% | +3.7% |
| Q4 2021 | $697,000 | -0.6% | 700,000 | 0.0% | 0.08% | -10.0% |
| Q3 2021 | $701,000 | +1.3% | 700,000 | 0.0% | 0.09% | +3.4% |
| Q2 2021 | $692,000 | -4.6% | 700,000 | 0.0% | 0.09% | -6.5% |
| Q1 2021 | $725,000 | -14.4% | 700,000 | -22.2% | 0.09% | -11.4% |
| Q4 2020 | $847,000 | +4.3% | 900,000 | 0.0% | 0.10% | -13.9% |
| Q3 2020 | $812,000 | +2.9% | 900,000 | 0.0% | 0.12% | -10.9% |
| Q2 2020 | $789,000 | -4.5% | 900,000 | -10.0% | 0.14% | -12.2% |
| Q1 2020 | $826,000 | -4.3% | 1,000,000 | 0.0% | 0.16% | +28.9% |
| Q4 2019 | $863,000 | – | 1,000,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|